Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses
B16-F10 tumor-bearing mice were injected intratumorally with PBS, anti-CD25 antibody, isotype-Ce6, or anti-CD25-Ce6, and PDT was performed twice on a 2-day interval. Next, 25 PFU of PR8 was intranasally administered after PDT completion. PR8 NP 366-374 -specific CD8 + T cells in lungs were monitored using flow cytometry with the H2-Db-NP 366-374 pentamer 7 days after PR8 infection. Data are shown as bar graphs of the frequency of PR8 NP366-374-specific CD8 + T cells; each dot represents an individual mouse.
